Taken together, these data suggest that the reduced expression of Sprtn leads to development of various progeroid phenotypes, including dwarfism, cataracts, lordokyphosis, fat tissue dysfunction and accumulation of senescent cells. The gene discussed is SPRTN; the disease is cataract.